UAE

Under the agreement, Mediclinic Middle East will engage with HealthTech startups within Hub71+ Life Sciences to identify potential collaborations and provide clinical guidance.

Under the agreement, ADSCC will contribute its cell therapy development and manufacturing infrastructure, while Miltenyi will provide scientific and technical support for its proprietary viral vector and anti-CD19 chimeric antigen receptor technologies.

Mediclinic Middle East is exploring how ambient AI can capture relevant information from clinician-patient conversations and convert it into structured clinical notes for review, reducing the need for manual documentation during consultations.

The project will increase inpatient and outpatient capacity, upgrade existing departments and introduce new orthopaedic and physiotherapy services.

The women’s health and fertility portfolio will cover several stages of reproductive health, including fertility, pregnancy and childbirth.

The clinic brings together specialists in surgery, oncology, radiology, and reconstruction, along with nursing and patient coordination services.

The opening expands the hospital’s oncology services as healthcare providers increasingly focus on coordinated cancer care those addresses treatment needs, side effects and patients’ quality of life.

The proposed partnership will combine Burjeel’s oncology services and clinical research infrastructure with Avatrial’s artificial intelligence (AI) and multi-omics technologies.

The partnership combines Dell’s global cybersecurity capabilities with PureCS’s locally based infrastructure and regional expertise to help organisations identify threats earlier, respond to incidents and protect critical systems.

The approach will allow Cinfa to build its regional operations incrementally while developing expertise and infrastructure within the UAE.